Outcome of overt stroke in sickle cell anaemia, a single institution's experience

British Journal of Haematology

Volumn 165, Issue 5, 2014, Pages 707-713

  Majumdar, Suvankar ^a   Miller, Morgan ^a   Khan, Majid ^a   Gordon, Catherine ^a   Forsythe, Amy ^a   Smith, Mary G ^a   Megason, Gail ^a   Iyer, Rathi ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Aspirin; Platelet; Sickle cell anaemia; Stroke; Survival

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL HISTORY; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SICKLE CELL ANEMIA; ANEMIA, SICKLE CELL; COMPLICATION; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; SECONDARY PREVENTION; STROKE; SURVIVAL; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ASPIRIN; CHILD; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SECONDARY PREVENTION; STROKE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84900492211     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12795     Document Type: Article

References (20)

1. Ataga, K.I. & Key, N.S. (2007) Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology American Society of Hematology Education Program, 1, 91-96.
2. Bader-Meunier, B., Verlhac, S., Elmaleh-Berges, M., Ithier, G., Sellami, F., Faid, S., Missud, F., Ducrocq, R., Alberti, C., Zaccaria, I., Baruchel, A. & Benkerrou, M. (2009) Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia. Haematologica, 94, 123-126.
3. Baigent, C., Blackwell, L., Collins, R., Emberson, J., Godwin, J., Peto, R., Buring, J., Hennekens, C., Kearney, P., Meade, T., Patrono, C., Roncaglioni, M.C. & Zanchetti, A. (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet, 373, 1849-1860.
4. Balkaran, B., Char, G., Morris, J.S., Thomas, P.W., Serjeant, B.E. & Serjeant, G.R. (1992) Stroke in a cohort of patients with homozygous sickle cell disease. Journal of Pediatrics, 120, 360-366.
5. Bishop, S., Matheus, M.G., Abboud, M.R., Cane, I.D., Adams, R.J., Jackson, S.M. & Kalpatthi, R. (2011) Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia. Blood Cells, Molecules, & Diseases, 47, 125-128.
6. Brousse, V., Hertz-Pannier, L., Consigny, Y., Bresson, J.L., Girot, R., Mirre, E., Lenoir, G. & de Montalembert, M. (2009) Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease? Annals of Hematology, 88, 785-788.
7. Charneski, L. & Congdon, H.B. (2010) Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: a review of the literature. American Journal of Health System Pharmacy, 67, 895-900.
8. Cohen, A.R., Martin, M.B., Silber, J.H., Kim, H.C., Ohene-Frempong, K. & Schwartz, E. (1992) A modified transfusion program for prevention of stroke in sickle cell disease. Blood, 79, 1657-1661.
9. Debaun, M.R., Armstrong, F.D., McKinstry, R.C., Ware, R.E., Vichinsky, E. & Kirkham, F.J. (2012) Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood, 119, 4587-4596.
10. He, J., Whelton, P.K., Vu, B. & Klag, M.J. (1998) Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA, 280, 1930-1935.
11. Lansberg, M.G., O'Donnell, M.J., Khatri, P., Lang, E.S., Nguyen-Huynh, M.N., Schwartz, N.E., Sonnenberg, F.A., Schulman, S., Vandvik, P.O., Spencer, F.A., Alonso-Coello, P., Guyatt, G.H. & Akl, E.A. (2012) Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest, 141, e601S-e636S.
12. Majumdar, S., Robertson, Z., Robinson, A., Starnes, S., Iyer, R. & Megason, G. (2010) Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience. Bone Marrow Transplantation, 45, 895-900.
13. Majumdar, S., Webb, S., Norcross, E., Mannam, V., Ahmad, N., Lirette, S. & Iyer, R. (2013) Stroke with intracranial stenosis is associated with increased platelet activation in sickle cell anemia. Pediatric Blood & Cancer, 60, 1192-1197.
14. McCavit, T.L., Xuan, L., Zhang, S., Flores, G. & Quinn, C.T. (2013) National trends in incidence rates of hospitalization for stroke in children with sickle cell disease. Pediatric Blood & Cancer, 60, 823-827.
15. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H. & Gill, F.M. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288-294.
16. Pegelow, C.H., Adams, R.J., McKie, V., Abboud, M., Berman, B., Miller, S.T., Olivieri, N., Vichinsky, E., Wang, W. & Brambilla, D. (1995) Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. Journal of Pediatrics, 126, 896-899.
17. Powars, D., Wilson, B., Imbus, C., Pegelow, C. & Allen, J. (1978) The natural history of stroke in sickle cell disease. American Journal of Medicine, 65, 461-471.
18. Russell, M.O., Goldberg, H.I., Hodson, A., Kim, H.C., Halus, J., Reivich, M. & Schwartz, E. (1984) Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood, 63, 162-169.
19. Scothorn, D.J., Price, C., Schwartz, D., Terrill, C., Buchanan, G.R., Shurney, W., Sarniak, I., Fallon, R., Chu, J.Y., Pegelow, C.H., Wang, W., Casella, J.F., Resar, L.S., Berman, B., Adamkiewicz, T., Hsu, L.L., Ohene-Frempong, K., Smith-Whitley, K., Mahoney, D., Scott, J.P., Woods, G.M., Watanabe, M. & Debaun, M.R. (2002) Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. Journal of Pediatrics, 140, 348-354.
20. Ware, R.E., Schultz, W.H., Yovetich, N., Mortier, N.A., Alvarez, O., Hilliard, L., Iyer, R.V., Miller, S.T., Rogers, Z.R., Scott, J.P., Waclawiw, M. & Helms, R.W. (2011) Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. Pediatric Blood & Cancer, 57, 1011-1017.